国际妇产科学杂志

国际妇产科学杂志 ›› 2011, Vol. 38 ›› Issue (6): 550-553.

• 综述 • 上一篇    下一篇

宫颈癌患者生活质量研究进展

奚美丽,鹿 欣   

  1. 200011 上海,复旦大学附属妇产科医院妇产科
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2011-12-15 发布日期:2011-12-15
  • 通讯作者: 鹿 欣

Progress in Study on Quality of Life of Patients with Cervical Carcinoma

XI Mei-li，LU Xin   

  1. Department of Obstetrics and Gynecology，Obstetrics and Gynecology Hospital of Fudan University，Shanghai 200011，China
  • Received:1900-01-01 Revised:1900-01-01 Published:2011-12-15 Online:2011-12-15
  • Contact: LU Xin

PDF (PC)

4731

摘要： 随着医疗模式的改变及癌症患者生存率的提高，提高癌症患者生活质量已越来越受到人们的关注。宫颈癌是女性第二大恶性肿瘤，患者预后较好，治疗后有较长的无瘤生存期。近年来，有关改善宫颈癌患者治疗后生活质量的研究取得很大进展。国内外妇科肿瘤医师在宫颈癌手术治疗方面，开展了保留生育功能的广泛宫颈根治手术、保留内分泌功能的手术和保留神经功能的手术等。改进后手术方式的安全性和可行性已获得广泛肯定，术后患者的生活质量明显改善，得到患者的认可。在宫颈癌辅助治疗方面，放化疗必不可少，但在改善患者预后的同时，其并发症也较多，对生活质量的影响值得探讨。综述国内外宫颈癌患者生活质量的研究进展

关键词: 宫颈肿瘤, 生活质量, 妇科外科手术, 抗肿瘤联合化疗方案, 治疗

Abstract: The improvement of quality of life in cancer patients became an important issue in clinic along with the progress of treatment and the increasing survival rate. Cervical cancer is the second common gynecological cancer in women. The patients with cervical cancer have good prognosis and long survival with free tumor. Recently，gynecological oncologists have made great progress in the field of improvement of quality of life in cervical cancer. Various modified operation procedures aiming to improve quality of life of which the safety and feasibility have been widely adapted in early-stage cervical cancer，such as fertility-sparing radical trachelectomy， ovarian transposition as well as nerve-sparing radical hysterectomy. Adjuvant therapies including chemotherapy and radiotherapy have been commonly used in improving prognosis of cervical cancer patients. However， the impacts on quality of life need to be considered because of sequentially complications.The progress in improving quality of life in cervical cancer patients has been reviewed in this article.

Key words: Uterine cervical neoplasms, Quality of life, Gynecologic surgical procedures, Antineoplastic combined chemotherapy protocols, Therapy